Tezepelumab as a therapeutic alternative in allergic bronchopulmonary aspergillosis suboptimally controlled by omalizumab

Andreina María Mugno-Saba, Stephanie Steixner-Zevallos, María Reyes Pérez-Giménez, Laura Manzanedo-Ortega, Diana Alejandra D’Elia-Torrence

Open source

DOI: 10.1080/02770903.2026.2759483
Published: 2026-11-05
Container: Journal of Asthma
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/02770903.2026.2759483,
  title = {Tezepelumab as a therapeutic alternative in allergic bronchopulmonary aspergillosis suboptimally controlled by omalizumab},
  author = {Andreina María Mugno-Saba and Stephanie Steixner-Zevallos and María Reyes Pérez-Giménez and Laura Manzanedo-Ortega and Diana Alejandra D’Elia-Torrence},
  year = {2026},
  journal = {Journal of Asthma},
  doi = {10.1080/02770903.2026.2759483},
  url = {https://doi.org/10.1080/02770903.2026.2759483}
}

RIS

TY  - JOUR
TI  - Tezepelumab as a therapeutic alternative in allergic bronchopulmonary aspergillosis suboptimally controlled by omalizumab
AU  - Andreina María Mugno-Saba
AU  - Stephanie Steixner-Zevallos
AU  - María Reyes Pérez-Giménez
AU  - Laura Manzanedo-Ortega
AU  - Diana Alejandra D’Elia-Torrence
PY  - 2026
JO  - Journal of Asthma
DO  - 10.1080/02770903.2026.2759483
UR  - https://doi.org/10.1080/02770903.2026.2759483
ER  -

APA

Mugno-Saba, A. M., Steixner-Zevallos, S., Pérez-Giménez, M. R., Manzanedo-Ortega, L., & D’Elia-Torrence, D. A. (2026). Tezepelumab as a therapeutic alternative in allergic bronchopulmonary aspergillosis suboptimally controlled by omalizumab. Journal of Asthma. https://doi.org/10.1080/02770903.2026.2759483

Source records

crossref · retrieved 2026-11-10T14:40:56.059Z